Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
第一作者:
D,Choi
第一单位:
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0666, USA.
作者:
医学主题词
抗原, CD34(Antigens, CD34);癌症疫苗(Cancer Vaccines);细胞分离(Cell Separation);细胞, 培养的(Cells, Cultured);树突细胞(Dendritic Cells);可行性研究(Feasibility Studies);流式细胞术(Flow Cytometry);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);造血干细胞移植(Hematopoietic Stem Cell Transplantation);造血干细胞(Hematopoietic Stem Cells);人类(Humans);免疫法(Immunization);白细胞去除术(Leukapheresis);白细胞, 单核(Leukocytes, Mononuclear);淋巴细胞亚群(Lymphocyte Subsets);肿瘤(Neoplasms);表型(Phenotype);移植预处理(Transplantation Conditioning)
PMID
9829733
发布时间
2007-11-14
基金项目
1 P01 CA59327/CA/NCI NIH HHS/United States
M01-RR00042/RR/NCRR NIH HHS/United States
- 浏览6
Clinical cancer research
2709-16页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



